Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach?

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
JournalVaccines
Publication statusPublished - 22 Nov 2024

Cite this